IP Verse

Process For Drying Of Bibw2992, Of Its Salts And Of Solid Pharmaceutical Formulations Comprising This Active Ingredient - EP2451445

The patent EP2451445 was granted to Boehringer Ingelheim on Apr 3, 2019. The application was originally filed on Jul 5, 2010 under application number EP10730454A. The patent is currently recorded with a legal status of "Revoked".

EP2451445

BOEHRINGER INGELHEIM
Application Number
EP10730454A
Filing Date
Jul 5, 2010
Status
Revoked
Dec 13, 2024
Grant Date
Apr 3, 2019
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (3)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

GENERICS UKDec 27, 2019HGFADMISSIBLE
LEK PHARMACEUTICALS DDDec 20, 2019TER MEER STEINMEISTER & PARTNERADMISSIBLE
TEVA PHARMACEUTICALSNov 20, 2019KRAUS & LEDERER PARTGMBBADMISSIBLE

Patent Citations (15) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
DESCRIPTIONWO0250043
DESCRIPTIONWO2005037824
DESCRIPTIONWO2007054550
DESCRIPTIONWO2007054551
INTERNATIONAL-SEARCH-REPORTUS2005085495
INTERNATIONAL-SEARCH-REPORTWO0250043
OPPOSITIONUS2003186956
OPPOSITIONUS2005085495
OPPOSITIONWO0250043
OPPOSITIONWO2007054550
OPPOSITIONWO2008034776
OPPOSITIONWO2009147238
OPPOSITIONWO2011003853
OTHERUS2005085495
OTHERWO0250043

Non-Patent Literature (NPL) Citations (10) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
OPPOSITION- Anonymous, "<922> Water Activity", USP-NF General Announcement, (20180430), pages 1 - 3, URL: https://www.uspnf.com/notices/922-water-activity, XP055653987-
OPPOSITION- Anonymous, "<922> Water Activity", USP-NF General Announcement, pages 1 - 3, USP-NF General Announcement, URL: https://www.uspnf.com/notices/922-water-activity, (20191218), XP055653987-
OPPOSITION- Anonymous, "Water activity, Wikipedia the free encyclopedia", (20071110), pages 1 - 5, URL: https://en.wikipedia.org/w/index.php?title=Water_activity&oldid=170527550, XP055653981-
OPPOSITION- Anonymous, "Water activity - Wikipedia the free encyclopedia", pages 1 - 5, URL: https://en.wikipedia.org/w/index.php?title=Water_activity&oldid=170527550, (20191218), XP055653981-
OPPOSITION- "Drying", Aulton Micheal, Pharmaceutics The science of dosage form design, (20020000), XP055306320-
OPPOSITION- "Kapitel 4", Ritschel W., Et Al., Die Tablette Handbuch der Entwicklung, Herstellung und Qualitätssicherung, (20020000), pages 284 - 288, XP055667165-
OPPOSITION- "Kapitel 5", Lippold Bernhard C., Et Al., Lehrbuch der pharmazeutischen Technologie, (20060000), XP055667170-
OPPOSITION- MICHAEL E. AULTON, PHARMACEUTICS - THE SCIENCE OF DOSAGE FORM DESIGN, Second Edition, Churchill Livingstone, (20020000), pages 379-383; 441 - 445, XP055653979-
OPPOSITION- Michael E. Aulton, "PHARMACEUTICS - THE SCIENCE OF DOSAGE FORM DESIGN, Second Edition /Passage/", PHARMACEUTICS - THE SCIENCE OF DOSAGE FORM DESIGN, Second Edition, Churchill Livingstone, (20020101), pages 379 - 445, XP055653979-
OPPOSITION- ESKENS F A L M ET AL, "A phase I dose escalation study of BIBW 2992, an irreversible dual inhibitor of epidermal growth factor receptor 1 (EGFR) and 2 (HER2) tyrosine kinase in a 2-week on, 2-week off schedule in patients with advanced solid tumours", British Journal of Cancer, Nature Publishing Group, GB, GB, (20080101), vol. 98, no. 1, doi:10.1038/sj.bjc.6604108, ISSN 0007-0920, pages 80 - 85, XP002542320

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents